BillionToOne drops after in-line quarter, maintains annual revenue outlook

BillionToOne

06/08/2026 13:34

** Shares of molecular diagnostics co BillionToOne BLLN.O fall 25.95% to $111.06 premarket
** Co maintained annual revenue forecast to be between $450.0 million and $465.0 million
** Q2 rev of $109.4 million were about in line with estimates
** BLLN came in hot into the Q2 print and surprised folks with an in-line quarter, says brokerage BTIG
** At least two brokerages cut PT on co
** Up to last close, stock up 83% YTD

 (Reporting by Sriparna Roy in Bengaluru)
 ((Sriparna.Roy@thomsonreuters.com;))